Lineage Cell Therapeutics Inc. Insider Trading

LCTX

⊜ Compare

Last 12 months

Insiders bought 24K on the open market and sold nothing.

Net open-market

+24K

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Mar 2026

Mar 12, 2026

Get an email when LCTX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 12	Brian M Culley President and CEO	Bought	15,000	$1.63	24K	6.2%	Form 4
Jan 27, 2025	Broadwood Capital INC Large holder	Bought 2 parts	7,894,737	$0.76 average	$6M	8.7%	Form 4
Nov 26, 2024	Jill Ann Howe Chief Financial Officer	Bought	15,000	$0.59	9K	143%	Form 4
Nov 26, 2024	George A. Samuel III General Counsel	Bought	15,000	$0.60	9K	209%	Form 4
Nov 22, 2024	Michael H. Mulroy Director	Bought	40,000	$0.57	23K	15%	Form 4
Nov 21, 2024	Brian M Culley President and CEO	Bought	40,000	$0.60	24K	26%	Form 4

Mar 12
Brian M Culley
President and CEO · bought 15,000 at $1.63
24K
6.2% of stake
Jan 27, 2025
Broadwood Capital INC
Large holder · bought 7,894,737 at avg $0.76
$6M
8.7% of stake
Nov 26, 2024
Jill Ann Howe
Chief Financial Officer · bought 15,000 at $0.59
9K
143% of stake
Nov 26, 2024
George A. Samuel III
General Counsel · bought 15,000 at $0.60
9K
209% of stake
Nov 22, 2024
Michael H. Mulroy
Director · bought 40,000 at $0.57
23K
15% of stake
Nov 21, 2024
Brian M Culley
President and CEO · bought 40,000 at $0.60
24K
26% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LCTX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with LCTX

CompareIntrinsic value

CRSPCrispr Therapeutics AG

$51.78+3.57%40

ALECAlector Inc.

$2.28+11.22%10

ELUTElutia Inc.

$0.76-6.52%20

RVMDRevolution Medicines Inc.

$199.21+2.56%10

SRZNSurrozen, Inc.

$31.65+5.08%10

ACOGAlpha Cognition Inc.

$8.49+3.48%10

RLAYRelay Therapeutics Inc.

$18.03+3.38%40

CRBUCaribou Biosciences, Inc.

$0.44-3.27%10

Held by ETFs

LCTX is in 4 US ETFs. The largest of them, with LCTX's weight in each:

Spot a number that looks wrong? Check it in LCTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LCTX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.